Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on developing solid tumor cell therapies to defeat cancer. Leveraging a diverse team of experts across multiple scientific disciplines and clinical and manufacturing experience, ArsenalBio is committed to engineering innovative treatments that target the complex nature of cancer. Utilizing a programmable and computationally driven approach, the company aims to improve patient outcomes by overcoming the challenges of solid tumors through advanced cell therapies.